Close

Biogen (BIIB) Completes Acquisition of Nightstar Therapeutics (NITE) Jun 7, 2019 08:07AM
Biogen Completes Acquisition of Nightstar Therapeutics for Approximately $800 Million Jun 7, 2019 05:41AM
Biogen (BIIB) to Acquire Nightstar Therapeutics (NITE) for $25.50/Sh in Deal Valued at Approx. $800M Mar 4, 2019 05:53AM
Biogen Announces Agreement to Acquire Nightstar Therapeutics to Establish Clinical Pipeline of Gene Therapy Candidates in Ophthalmology Mar 4, 2019 02:00AM
Decibel Therapeutics Bolsters Leadership Team with Appointments of Chief Medical Officer and Chief Operating Officer Feb 5, 2019 07:00AM


Oct 3, 2017 04:00AM Citi Appointed as Depositary Bank for Nightstar’s ADR Programme
Sep 28, 2017 06:00AM Nightstar Therapeutics (Nasdaq: NITE) to Ring The Nasdaq Stock Market Closing Bell in Celebration of Its IPO